Cheng Liu

Title: Innovations by Cheng Liu in Targeted Therapies

Introduction

Cheng Liu is an accomplished inventor based in Carlsbad, CA (US). He has made significant contributions to the field of medical science, particularly in the development of targeted therapies for cancer treatment. With a total of 2 patents to his name, Liu's work focuses on innovative methods for delivering therapeutic agents to specific cells.

Latest Patents

Liu's latest patents include "Targeted delivery to legumain-expressing cells" and "Targeted thrombosis." The first patent relates to new agents and methods useful for preventing, treating, and diagnosing diseases such as cancer. This invention involves prodrug agents that target and deliver cytotoxic drugs specifically to cancerous cells. The second patent provides compositions and methods to initiate site-specific thrombosis in tumor vasculature, offering new avenues for treating tumors effectively.

Career Highlights

Cheng Liu is affiliated with The Scripps Research Institute, where he continues to advance his research and innovations. His work has garnered attention for its potential to improve cancer treatment outcomes through targeted delivery systems.

Collaborations

Liu collaborates with notable professionals in his field, including Thomas S. Edgington, enhancing the impact of his research through shared expertise and knowledge.

Conclusion

Cheng Liu's innovative work in targeted therapies represents a significant advancement in cancer treatment methodologies. His patents reflect a commitment to improving patient outcomes through precise medical interventions.